Phase II study shows potential benefit of adenoviral vascular endothelial growth factor C (VEGF-C) and lymph node transfer in lymphedema.
Rannikko EH, Pajula S, Suominen SH, Kiiski J, Mani MR, Halle M, Kaartinen IS, Lahdenperä O, Arnardottir TH, Kauhanen SM, Kavola H, Majava M, Niemi TS, Brück NM, Mäki MT, Seppänen MP, Saarikko AM, Hartiala P.
Rannikko EH, et al. Among authors: maki mt.
Plast Reconstr Surg. 2024 Aug 12. doi: 10.1097/PRS.0000000000011675. Online ahead of print.
Plast Reconstr Surg. 2024.
PMID: 39137430